Author's Reply to Zheng et al.: A Physiologically Based Pharmacokinetic Drug-Disease Model to Predict Carvedilol Exposure in Adult and Paediatric Heart Failure Patients by Incorporating Pathophysiological Changes in Hepatic and Renal Blood Flows.

Rasool, Muhammad Fawad; Khalil, Feras; Läer, Stephanie

Rasool, Muhammad Fawad; Khalil, Feras; Läer, Stephanie.

Affiliation

Rasool MF; Department of Clinical Pharmacy and Pharmacotherapy, Heinrich-Heine University, 40225, Düsseldorf, Germany. fawadrasool@bzu.edu.pk.
Khalil F; Faculty of Pharmacy, Bahauddin Zakariya University, Multan, 60800, Pakistan. fawadrasool@bzu.edu.pk.
Läer S; Department of Clinical Pharmacy and Pharmacotherapy, Heinrich-Heine University, 40225, Düsseldorf, Germany.

Clin Pharmacokinet ; 55(1): 139-41, 2016 Jan.

Article in En | MEDLINE | ID: mdl-26649872

Subject(s)

Carbazoles/pharmacokinetics; Heart Failure/drug therapy; Heart Failure/metabolism; Liver Circulation/drug effects; Models, Biological; Propanolamines/pharmacokinetics; Renal Circulation/drug effects; Female; Humans; Male

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Propanolamines / Renal Circulation / Carbazoles / Heart Failure / Liver Circulation / Models, Biological Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Clin Pharmacokinet Year: 2016 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google